Visionary Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,050
Closed -$251K 536
2024
Q2
$251K Sell
6,050
-2,401
-28% -$107K 0.02% 445
2024
Q1
$458K Buy
8,451
+581
+7% +$29.6K 0.03% 336
2023
Q4
$404K Sell
7,870
-499
-6% -$26.2K 0.03% 352
2023
Q3
$486K Sell
8,369
-547
-6% -$33.5K 0.04% 306
2023
Q2
$570K Sell
8,916
-536
-6% -$35.9K 0.05% 273
2023
Q1
$655K Buy
9,452
+1,676
+22% +$118K 0.06% 248
2022
Q4
$560K Buy
7,776
+637
+9% +$48K 0.05% 224
2022
Q3
$507K Sell
7,139
-50
-0.7% -$3.63K 0.05% 224
2022
Q2
$554K Sell
7,189
-1,322
-16% -$101K 0.05% 228
2022
Q1
$622K Sell
8,511
-1,630
-16% -$109K 0.05% 227
2021
Q4
$632K Buy
10,141
+2,514
+33% +$147K 0.05% 207
2021
Q3
$451K Buy
7,627
+99
+1% +$6.52K 0.05% 201
2021
Q2
$503K Buy
7,528
+1,583
+27% +$103K 0.05% 202
2021
Q1
$375K Buy
5,945
+386
+7% +$24K 0.04% 222
2020
Q4
$345K Buy
5,559
+145
+3% +$8.92K 0.04% 219
2020
Q3
$326K Buy
5,414
+805
+17% +$48.5K 0.05% 185
2020
Q2
$271K Buy
4,609
+804
+21% +$48.1K 0.04% 183
2020
Q1
$212K Sell
3,805
-249
-6% -$15.2K 0.04% 185
2019
Q4
$261K Buy
+4,054
New +$232K 0.05% 177

Other funds holding BMY

Visionary Wealth Advisors's BMY Position: Q3 2024 in Review

Visionary Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 6,050 shares — an estimated $251K sold.

Visionary Wealth Advisors first reported a position in BMY in Q4 2019 and held it in 19 quarters. The position peaked at $655K in Q1 2023. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Visionary Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Visionary Wealth Advisors sold 6,050 Bristol-Myers Squibb shares in Q3 2024, an estimated $251K.
  • Visionary Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 19 quarters.
  • Visionary Wealth Advisors's Bristol-Myers Squibb position peaked at $655K in Q1 2023.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Visionary Wealth Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.